Instructions for Activated carbon pills
English product name
Activated charcoal
Release form
tab. 250 mg: 10, 20, 30, 50 or 5,000 units
Description:
Tablets 1 tab.
activated carbon 250 mg
ATX codes
A07BA01 Medicinal charcoal
Clinical-pharmacological groups / Group affiliation
Enterosorbent
Active substance
Activated carbon
Pharmacotherapy group
Enterosorbiting agent
Testimony Activated carbon:
- Exogenous and endogenous intoxications of different origins (as a detoxifying agent).
- Food toxicoinfections,
- dysentery,
- salmonellosis (in complex treatment).
- Poisoning with drugs (psychotropic,
- sleeping pills,
- narcotic drugs,
- etc.), alkaloids,
- heavy metal salts,
- and other poisons.
- Diseases of cardiovascular tissue accompanied by dyspepsia and meteorism.
- Food and drug allergies.
- Hyperbilirubinemia,
- hyperasothemia.
- To reduce gas formation in the intestine before ultrasound and radiological studies.
- In order to prevent chronic intoxication in harmful production.
Method of application, course and dosage Activated carbon:
Inside. Individual dosing regime, depending on the indications, clinical situation and age of the patient.
Use in children
Use in children under 3 years of age is contraindicated.
- Nosology (ICD codes)
- A01
- Typhus and parathyphus
- A02
- Other salmonella infections
- A03
- Shigellosis
- A05
- Other bacterial food poisoning not classified in other headings
- K29
- Gastritis and duodenite
- K30
- Functional dyspepsia (digestive disorder)
- R14
- Flatulence and related states (including bloating, burping)
- T50.9
- Other and unspecified drugs, medicines and biological substances
- T56
- Toxic effects of metals
- T78.4
- Unspecified allergy
- Z51.4
- Preparatory procedures for follow-up treatment or examination not classified elsewhere
Pharmacological effect Activated carbon:
Adsorber. It has enterosorbent, detoxifying and antidiarrhea effect. It is a member of the group of polyvalent physical-chemical antidotes, it possesses a large surface activity. Adsorb poisons and toxins from the LCI prior to their intake, including alkaloids, glycosides, barbiturates and other sleeping and narcotic agents, heavy metal salts, bacterial, plant and animal toxins derivatives of phenol, synylic acid, sulfanilamides, gases. Also absorbs excess of some metabolic products - bilirubin, urea, cholesterol, endogenous metabolites, responsible for the development of endogenous toxicosis. Weak absorption of acids and alkalis (including iron salts, cyanide, methanol, ethylene glycol). Does not irritate the LCI mucosa.
